ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,086.37
      0.61%
      US Tech 100
      21,234.80
      1.16%
      Dow Jones
      44,156.73
      0.30%
      Brent Oil
      78.335
      -0.53%
      Bitcoin
      104,060.45
      -1.99%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG

      6. ATAI Life Sciences NV (9VC) Quote

      ATAI Life Sciences NV

      ATAI Life Sciences NV (9VC)

      TG
      1.4555
      0.0205
      (1.43%)
      Closed January 22 4:00PM
      Realtime Data

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.4555
      Bid
      1.4285
      Ask
      1.4815
      Volume
      1,470
      1.4275 Day's Range 1.5035
      0.93 52 Week Range 2.529
      Market Cap
      244.236M
      Previous Close
      1.435
      Open
      1.48
      Last Trade
      400
      @
      1.4845
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      22,343
      Shares Outstanding
      167,802,396
      Dividend Yield
      -
      PE Ratio
      -6.30
      Earnings Per Share (EPS)
      -0.24
      Revenue
      314k
      Net Profit
      -40.22M

      About ATAI Life Sciences NV

      Sector
      Intermediate Care Facilities
      Industry
      Intermediate Care Facilities
      Website
      www.atai.life
      Headquarters
      Berlin, Deu
      Founded
      -
      ATAI Life Sciences NV is listed in the Intermediate Care Facilities sector of the Tradegate (DE) with ticker 9VC. The last closing price for ATAI Life Sciences NV was 1.44 €. Over the last year, ATAI Life Sciences NV shares have traded in a share price range of 0.93 € to 2.529 €.

      ATAI Life Sciences NV currently has 167,802,396 shares outstanding. The market capitalization of ATAI Life Sciences NV is 240.80 € million. ATAI Life Sciences NV has a price to earnings ratio (PE ratio) of -6.30.

      Ask ADVFN Intelligence (AI)

      9VC Latest News

      More News

      atai Life Sciences gibt Finanzergebnisse des zweiten Quartals 2023 und operative Highlights sowie klinische Daten aus der Phase-1-Studie mit DMX-1002 (Ibogain) bekannt

      atai Life Sciences gibt Finanzergebnisse des zweiten Quartals 2023 und operative Highlights sowie klinische Daten aus der Phase-1-Studie mit DMX-1002 (Ibogain) bekannt Mehrere Wirkstoffe im...

      August 14 2023
      GlobeNewswire Inc.

      atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

      atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) Advanced multiple...

      August 10 2023
      GlobeNewswire Inc.

      atai Life Sciences gibt Ergebnisse der Phase-I-Studie zum Übergang von intravenöser zu subkutaner Verabreichung von PCN-101 (R-Ketamin) bekannt

      atai Life Sciences gibt Ergebnisse der Phase-I-Studie zum Übergang von intravenöser zu subkutaner Verabreichung von PCN-101 (R-Ketamin) bekannt NEW YORK und BERLIN, Aug. 09, 2023 (GLOBE...

      August 09 2023
      GlobeNewswire Inc.

      atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

      atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine) NEW YORK and BERLIN, Aug. 08, 2023 (GLOBE NEWSWIRE) -- atai Life...

      August 08 2023
      GlobeNewswire Inc.

      atai Life Sciences nimmt an kommenden Investorenkonferenzen im Juni teil

      atai Life Sciences nimmt an kommenden Investorenkonferenzen im Juni teil NEW YORK und BERLIN, June 05, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) („atai“), ein im klinischen...

      June 05 2023
      GlobeNewswire Inc.

      atai Life Sciences to Participate in Upcoming June Investor Conferences

      atai Life Sciences to Participate in Upcoming June Investor Conferences NEW YORK and BERLIN, June 01, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage...

      June 01 2023
      GlobeNewswire Inc.

      atai Life Sciences legt Finanzergebnisse für das erste Quartal 2023 vor und gibt Highlights und Updates zur Pipeline bekannt

      atai Life Sciences legt Finanzergebnisse für das erste Quartal 2023 vor und gibt Highlights und Updates zur Pipeline bekannt RL-007: Erster Patient in der Phase-IIb-Studie zu RL-007 bei...

      May 17 2023
      GlobeNewswire Inc.

      atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates

      atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates RL-007: First patient dosed in the Phase 2b study of RL-007 in Cognitive...

      May 11 2023
      GlobeNewswire Inc.

      atai Life Sciences ist Teilnehmer der im Mai stattfindenden Investorenkonferenz

      atai Life Sciences ist Teilnehmer der im Mai stattfindenden Investorenkonferenz NEW YORK und BERLIN, May 03, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) („atai“), ein...

      May 03 2023
      GlobeNewswire Inc.

      atai Life Sciences to Participate in Upcoming May Investor Conference

      atai Life Sciences to Participate in Upcoming May Investor Conference NEW YORK and BERLIN, May 02, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage...

      May 02 2023
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.13910.55829851881.31651.551.3154999105231.42465125DE
      40.221517.94975688821.2341.82951.202214761.58778545DE
      120.37935.20668834181.07651.8440.93223431.43859994DE
      260.0694.976559682651.38651.8440.93138451.34776569DE
      52-0.1265-7.996207332491.5822.5290.93138001.56582321DE
      156-2.7445-65.34523809524.25.60.9371831.60625834DE
      260-9.2445-86.397196261710.7130.9368741.63594896DE

      9VC - Frequently Asked Questions (FAQ)

      What is the current ATAI Life Sciences NV share price?
      The current share price of ATAI Life Sciences NV is 1.4555 €
      How many ATAI Life Sciences NV shares are in issue?
      ATAI Life Sciences NV has 167,802,396 shares in issue
      What is the market cap of ATAI Life Sciences NV?
      The market capitalisation of ATAI Life Sciences NV is EUR 240.8M
      What is the 1 year trading range for ATAI Life Sciences NV share price?
      ATAI Life Sciences NV has traded in the range of 0.93 € to 2.529 € during the past year
      What is the PE ratio of ATAI Life Sciences NV?
      The price to earnings ratio of ATAI Life Sciences NV is -6.3
      What is the cash to sales ratio of ATAI Life Sciences NV?
      The cash to sales ratio of ATAI Life Sciences NV is 794.74
      What is the reporting currency for ATAI Life Sciences NV?
      ATAI Life Sciences NV reports financial results in USD
      What is the latest annual turnover for ATAI Life Sciences NV?
      The latest annual turnover of ATAI Life Sciences NV is USD 314k
      What is the latest annual profit for ATAI Life Sciences NV?
      The latest annual profit of ATAI Life Sciences NV is USD -40.22M
      What is the registered address of ATAI Life Sciences NV?
      The registered address for ATAI Life Sciences NV is WALLSTRABE 16, BERLIN, 10179
      What is the ATAI Life Sciences NV website address?
      The website address for ATAI Life Sciences NV is www.atai.life
      Which industry sector does ATAI Life Sciences NV operate in?
      ATAI Life Sciences NV operates in the INTERMEDIATE CARE FACILITIES sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      PNYPine Technology Holdings Ltd
      0.0065 €
      (44.44%)
      		35k
      AAHAhlers AG
      0.01 €
      (42.86%)
      		12k
      38ERekor Systems Inc
      1.984 €
      (32.09%)
      		39.11k
      L7C2Windfall Geotek Inc
      0.011 €
      (29.41%)
      		11.72k
      9AJ1Altiplano Metals Inc
      0.0438 €
      (28.82%)
      		13.61k
      432Arbor Metals Corp
      0.318 €
      (-43.82%)
      		2.11M
      PQWNPacific Ridge Exploration Ltd
      0.007 €
      (-41.67%)
      		36.12k
      BDDOrdinary Shares
      0.0034 €
      (-41.38%)
      		10.6k
      R1EAEV Resources Ltd
      0.0012 €
      (-40.01%)
      		6.08k
      E3O1Nexoptic Technology Corp
      0.0095 €
      (-38.71%)
      		12.79k
      D7GNel ASA
      0.1905 €
      (-1.55%)
      		4.93M
      PF8European Lithium Limited
      0.0408 €
      (-8.11%)
      		3.57M
      RQ0DWave Quantum Inc
      6.016 €
      (-0.76%)
      		3.27M
      SHA0Schaeffler AG
      3.96 €
      (-9.02%)
      		2.31M
      24YBrainchip Holdings Ltd
      0.2318 €
      (14.19%)
      		2.19M

      Discussion

      View Full Feed
      xxxx xxxx 54 seconds ago
      ...

      Shiba Strong ...
      SHIBUSD
      Gmenfan Gmenfan 58 seconds ago
      OMG ... That's hilarious!!!
      firebag1 firebag1 2 minutes ago
      pro tip 2 - stfu
      HMBL
      Ex-brokerBry Ex-brokerBry 2 minutes ago
      I myself expect a pullback.25% maxed out possibly.On the flip side this might just keep running all the way past a quarter.I make 11,000 on every penny it goes up.Can't remember the last time I had a runner like this.Not selling any of my 1.1 M ...making more butter popcorn and having a cold beer.
      UMAV
      xxxx xxxx 2 minutes ago
      ...
      SHIBUSD
      Bull_Dolphin Bull_Dolphin 2 minutes ago
      10 4
      MysticalRaider80 MysticalRaider80 3 minutes ago
      I think we going to no paid very soon
      BIEL
      JOHNNY-VEGAS JOHNNY-VEGAS 3 minutes ago
      Very interesting play here.
      RGTI
      MasterBlastr MasterBlastr 3 minutes ago
      Do you really expect the new administration to do squat about any of that. It will get worse, with quack remedies approved without trials, because of their profit potential. That is the world we are about to enter.
      NWBO
      xxxx xxxx 3 minutes ago
      ...
      SHIBUSD
      xxxx xxxx 4 minutes ago
      ...
      SHIBUSD
      DA88 DA88 4 minutes ago
      Can you share with the class?
      LWLG
      Genz2 Genz2 5 minutes ago
      Methinks, you know what would be cool? If we were able to Google Steven K Sprague and find a picture of him and his horses!! The guy has just been ahead of his time, and I’m sure he was trying to make Rivetz and Wave shareholders a lot of money, but dark forces were working against him!! Maybe Tr
      xxxx xxxx 5 minutes ago
      ...
      SHIBUSD
      harlem111 harlem111 5 minutes ago
      S-3 Filed with SEC This prospectus is part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission, or the SEC, using a "shelf” registration or continuous offering process. Under this shelf registration process, we may, from time to time, sell any combinatio
      LEXX
      xxxx xxxx 6 minutes ago
      ...
      SHIBUSD
      Carjockey2 Carjockey2 6 minutes ago
      Why..I doubt anyone cares to be honest IMHO

      HMBL
      Deano361 Deano361 7 minutes ago
      Bad day today but when this gets the data results and they go to market on the drug, this is an easy 10x stock.
      LPTX
      zab zab 7 minutes ago
      Trump is just adorable,  his makeup was perfect. 
      BIG D 4 BIG D 4 8 minutes ago
      GO SAVING GRACE AND JJJ !! GREAT DAY !! WOW !! I CLEANED UP THE .0004 S !! 3 MILLION SHARES !! 55 MILLION STRONG !! i am happy !! now MEGA BUCKS FOR US LONGS !! GO MAGA !! I AM LOADED NOW !! to the moon soon !! fellow investors !! THE BIG D #1 !!!!
      MJNA
      Gmenfan Gmenfan 8 minutes ago
      Let's change "very common" to very uncommon and add "non existent" to the post.
      Huggy Bear Huggy Bear 9 minutes ago
      I will go out on a proverbial branch here and say I wouldn't be surprised one iota at all if Foote is reinstated here, and basically back to where the stock was pre new Circus Show blowing into town. The prodigal son of tumbleweeds, if one will.

      The whole new ploy, and promotion, exi
      HMBL
      jay_tee jay_tee 11 minutes ago
      Filter i require whatever it is you're sipping. Up to this point after all these years what has you blindly trusting Seamus? Filings would go a long way. Other than that what has Seamus done to build RNVA shareholders' trust? He moved two profitable assets and has left us with literally nothing in l
      RNVA
      Clark6290 Clark6290 12 minutes ago
      I see a lot of refutation here, I am focused like a laser. 🤠
      FNMA

      Your Recent History

      TG
      9VC
      ATAI Life Sciences NV
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads